Document is current
Any future updates will be listed below
-
Authors
Schäfer, Samuel
Smelik, Martin
Sysoev, Oleg
Zhao, Yelin
Eklund, Desiré
Lilja, Sandra
Gustafsson, Mika
Heyn, Holger
Julia, Antonio
Kovács, István A.
Loscalzo, Joseph
Marsal, Sara
Zhang, Huan
Li, Xinxiu
Gawel, Danuta
Wang, Hui
Benson, Mikael http://orcid.org/0000-0002-7753-9181
-
Funding
Funding for this research was provided by:
European Commission grant (848028≠767 2)
Swedish Cancer Society (CAN 2017/411)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 2 March 2023
Accepted: 12 March 2024
First Online: 20 March 2024
Declarations
:
: All psoriatic arthritis patients and healthy controls provided written informed consent to participate in the study. The study was approved by Hospital Universitari Vall d'Hebron Clinical Research Ethics Committee with reference number 20/0022. Protocols were reviewed and approved by the local institutional review board of each participating centre. This research conformed to the principles of the Helsinki Declaration. All experimental procedures related to the AIA mouse model were performed according to the guidelines provided by the Swedish Animal Welfare Act and approved by the Ethical Committee for Research on Animals in Stockholm, Sweden (N271-14). All experimental procedures related to the CIA mouse model were performed in accordance with protocols approved by the Animal Experimental Ethics Committee of Xuzhou Medical University (202012A162).
: Not applicable.
: MB is the scientific founder of Mavatar, Inc. DRG is employed by Mavatar, Inc. H.H. is co-founder and shareholder of Omniscope, SAB member of Nanostring and MiRXES, and consultant to Moderna and Singularity. JL is coscientific founder of Scipher Medicine. The remaining authors declare that they do not have any competing interests.
